In This Section

Program

Please note that this meeting will take place as an in-person event in San Diego and will not live-stream content for virtual participation. The meeting content will be recorded and made available as an on-demand program after the conference. Please see the registration page for details.

CME credit is available for in-person attendance for the designated sessions. On-demand presentations are not eligible for CME.

All presentations are scheduled to be live, in-person presentations at the date and time specified below unless noted otherwise. Program in progress.

*-Short talk from proffered abstract

Wednesday, November 13

Thursday, November 14

Friday, November 15

Saturday, November 16

Wednesday, November 13

REGISTRATION

3-7 p.m.

WELCOME AND Keynote Lecture

6- 7:30 p.m. | CME Eligible

  • Ash A. Alizadeh, Stanford University, Stanford, California
  • Clinical applications of liquid biopsy
    Howard I. Scher, Memorial Sloan Kettering Cancer Center, New York, New York

OPENING RECEPTION

7:30-9 p.m.

Thursday, November 14

CONTINENTAL BREAKFAST
7-8 A.M.

Plenary Session 1: Biology Behind Circulating Tumor Cells (CTCs) 

8-10:05 a.m. | CME Eligible

Session Chair: Catherine Alix-Panabières, University of Montpellier, Montpellier, France

  • The biology of metastasis-competent CTCs in colon and breast cancer
    Catherine Alix-Panabières, University of Montpellier, Montpellier, France
  • Sunitha Nagrath, University of Michigan, Ann Arbor, Michigan
  • The biology of CTCs
    Daniel A. Haber, Massachusetts General Hospital, Boston, Massachusetts

Short talks selected from proffered abstracts

Break

10:05-10:25 a.m.

Plenary Session 2: Biology of Plasma Biomarkers 

10:25-12:30 p.m. | CME Eligible

  • The biology of extracellular vesicles
    David C. Lyden, Weill Cornell Medicine, New York, New York
  • Viktor Adalsteinsson, Broad Institute of MIT and Harvard, Cambridge, Massachusetts
  • The biology of non-coding RNAs: From basic science to patients 
    George A. Calin, The University of Texas MD Anderson Cancer Center, Houston, Texas

Short talks selected from proffered abstracts

Lunch on Own / Free Time

12:30-2:45 p.m.

Plenary Session 3: New Technologies for Liquid Biopsy Analyses 

2:45-5:05 p.m. | CME Eligible

Session Chair: Maximilian Diehn, Stanford University, Stanford, California

  • CTCs
    Shana O. Kelley, Northwestern University, Chicago, Illinois
  • Ultra-sensitive ctDNA technologies
    Maximilian Diehn, Stanford University, Stanford, California
  • Heterogeneity of cancer-derived extracellular vesicles 
    Dolores Di Vizio, Cedars-Sinai Medical Center, Los Angeles, California
  • Circulating proteins
    Samir M. Hanash, The University of Texas MD Anderson Cancer Center, Houston, Texas

Short talks selected from proffered abstracts

Poster Session A / Reception 

5:15-7:45 p.m.

Evening off/ Dinner on Own

7:45 p.m.

Friday, November 15

CONTINENTAL BREAKFAST

7-8 a.m.

Plenary Session 4: Early Detection of Primary Cancer and Relapse

8-10:05 a.m. | CME Eligible

  • Jimmy Lin, Freenome, Inc., South San Francisco, California
  • Detection and prevention of cancer
    Lori Minasian, National Cancer Institute, Bethesda, Maryland
  • The CancerSEEK studies
    Nickolas Papadopoulos, Johns Hopkins Medicine, Baltimore, Maryland

Short talks selected from proffered abstracts

BreaK

10:05-10:25 a.m.

Plenary Session 5: Liquid Biopsy Detection and Monitoring of MRD 

10:25 a.m.- 12:15 p.m. | CME Eligible

Session Chair: Luis A. Diaz, Jr., Memorial Sloan Kettering Cancer Center, New York, New York

  • Early detection of MRD in cancer patients
    Klaus Pantel, University Medical Center Hamburg-Eppendorf, Hamburg, Germany 
  • ctDNA based detection of MRD in colon cancer
    Jeanne Tie, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia 
  • Liquid biopsy in head and neck cancers
    Scott V. Bratman, University of Toronto, Toronto, ON, Canada 

Short talks selected from proffered abstracts

Lunch on Own/ Free Time

12:15-2:30 p.m.

Plenary Session 6: Monitoring Tumor Evolution in Cancer Patients 

2:30-4:35 p.m. | CME Eligible

Session Chair: Klaus Pantel, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

  • Cell-free DNA fragmentomics for cancer detection and monitoring 
    Jillian A. Phallen, Johns Hopkins University School of Medicine, Baltimore, Maryland
  • Jacqui A. Shaw, University of Leicester, Leicester, England
  • Adam Widman, Memorial Sloan Kettering Cancer Center, New York, New York

Short talks selected from proffered abstracts

Poster Session B/ Reception

4:45- 7:15 p.m.

Evening off/ Dinner on Own

7:15 p.m.

Saturday , November 16

CONTINENTAL BREAKFAST

7-8 a.m.

Plenary Session 7: Liquid Biopsy and Immunotherapy

8-10:05 a.m. | CME Eligible

Session Chair: Luis A. Diaz, Jr., Memorial Sloan Kettering Cancer Center, New York, New York

  • Albrecht Stenzinger, University Hospital Heidelberg, Heidelberg, Germany 
  • Luis A. Diaz
  • Liquid biopsies in pediatric solid tumors
    Brian D. Crompton, Dana-Farber Cancer Institute, Boston, Massachusetts

Short talks selected from proffered abstracts

BREAK

10:05-10:25 a.m.

Plenary Session 8: Computational Science in Liquid Biopsy Analyses

10:25 a.m.- 12:30 p.m. | CME Eligible

Session Chair: Núria Malats Riera, Spanish National Cancer Research Centre (CNIO), Madrid, Spain  

  • Tommy Kaplan, The Hebrew University of Jerusalem, Jerusalem, Israel
  • Methods for tumor phenotype classification from circulating tumor DNA
    Gavin Ha, Fred Hutchinson Cancer Center, Seattle, Washington
  • Multimodal-data integration
    Núria Malats Riera, Spanish National Cancer Research Centre (CNIO), Madrid, Spain  

Short talks selected from proffered abstracts

Closing Comments / Departure

12:30 p.m.